BUDESONIDE/FORMOTEROL SANDOZ FORSPIRO 160 micrograms/4.5 micrograms/dose, powder for inhalation in a single-dose container 120 doses
Active ingredients: Budesonide, Formoterol fumarate dihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for inhalation120 dosesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BUDESONIDE/FORMOTEROL SANDOZ FORSPIRO 160 microgrammes/4,5 microgrammes/dose, poudre pour inhalation en récipient unidose
- Pharmaceutical form
- poudre pour inhalation
- Route of administration
- inhalée
- Presentation description
- 2 plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 60 dose(s) avec 2 inhalateur(s) en plastique
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Nov 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69728399CIP73017576CIP133400930175767Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUDÉSONIDEpoudre | 160 microgrammes · une dose délivrée | SA |
| FUMARATE DE FORMOTÉROL DIHYDRATÉpoudre | 4,5 microgrammes · une dose délivrée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.